Methods: Patients with CCMD-3-diagnosed schizophrenia requiring antipsychotic treatment were randomly assigned to open-label oral quetiapine or haloperidol decanoate for 21days.
方法符合CCMD - 3诊断标准的精神分裂症住院患者，采用随机对照、开放性研究治疗21天。
Methods: Patients with CCMD-3-diagnosed schizophrenia requiring antipsychotic treatment were randomly assigned to open-label oral quetiapine or haloperidol decanoate for 21days.
方法符合CCMD - 3诊断标准的精神分裂症住院患者，采用随机对照、开放性研究治疗21天。
应用推荐